The Center for Drug Evaluation and Research’s Small Business and Industry Assistance (CDER SBIA) group will host the FDA NanoDay Symposium 2022 on October 11th from 8:50 AM to 3:10 PM EASTERN. This event is free to the public, but registration is required.
This symposium will address drug development of products that contain nanomaterials and how the newly finalized industry guidance for products that contain nanomaterials can be implemented in filings to the FDA. Join participants from around the globe as speakers address such topics as:
- Reviewer perspectives on drug development and laboratory efforts to better understand the challenges of manufacturing products that contain nanomaterials.
- Safety evaluations of food contact surfaces that contain nanomaterials.
- The development of standard materials and methods for nanomaterials.
Dr. Anil Patri, NCTR Nanocore Director and chair of the FDA Nanotechnology Task Force, will present the welcome message and discuss nanomaterial standards development at FDA. Dr. Patri will also participate in the Question & Answer panel at the end of the symposium.
For event information, including the agenda and virtual attendance, please visit FDA NanoDay Symposium 2022.
To learn more about nanotechnology, please visit our research topic pages — nanotechnology at FDA and nanotechnology at NCTR.
